Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-19
DOI
10.1038/s41598-019-53051-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
- (2019) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease
- (2018) Lisa I. Backus et al. HEPATOLOGY
- Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
- (2018) Giuseppe Cabibbo et al. LIVER INTERNATIONAL
- Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
- (2018) Mizuki Nishibatake Kinoshita et al. JOURNAL OF HEPATOLOGY
- Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy
- (2018) Arash Vaziri et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
- (2018) Alberto Ferrarese et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
- (2017) Donna L. White et al. GASTROENTEROLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
- (2017) Juan Manuel Pascasio et al. JOURNAL OF HEPATOLOGY
- Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
- (2017) Lauren A. Beste et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
- (2017) Stacey B. Prenner et al. JOURNAL OF HEPATOLOGY
- Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
- (2016) Tania M Welzel et al. GUT
- Toward a more accurate estimate of the prevalence of hepatitis C in the United States
- (2015) Brian R. Edlin et al. HEPATOLOGY
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
- (2013) Troels K H Scheel et al. NATURE MEDICINE
- Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents
- (2012) F. Poordad et al. JOURNAL OF VIRAL HEPATITIS
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
- (2011) B. L. Pearlman et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
- (2009) Paul Feuerstadt et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started